IQVIA Holdings | IQV - Interest Income


IQVIA Holdings reported $10M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
Accenture USD 75.07M 3.47M Mar/2026
Agilent USD 15M 2M Dec/2025
Bruker USD 4.4M 1.5M Sep/2025
Celltrion KRW 779M 157.66M Mar/2026
Charles River Laboratories USD -0.3 1.02M Mar/2026
Cognizant Technology Solutions USD 27M 2M Dec/2025
Danaher USD 27M 14M Mar/2026
Dentsply International USD 4M 1000K Mar/2025
Dianthus Therapeutics USD 6.26M 2.61M Mar/2026
IBM USD 152M 20M Mar/2026
Illumina USD 0.87 10M Mar/2026
Infosys INR 5.91B 0 Dec/2024
Kangmei Pharma CNY 2.44M 635.78K Mar/2026
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Pharma Mar EUR 1.63M 3.17M Dec/2025
Qiagen NV USD 20M 4.93M Dec/2025
Quest Diagnostics USD 2M 1000K Mar/2026
Revvity USD 5.75M 5.75M Dec/2025
Sartorius EUR -31.8M 86.7M Dec/2025
Thermo Fisher Scientific USD 258M 258M Dec/2025
Tilray USD 12.83M 20.19M May/2024
Veradigm USD 1.7M 1.6M Sep/2022
Waters USD 5.67M 5.67M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M Mar/2026